BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 24, 2000
View Archived Issues
Corixa subscribes to Incyte's LifeSeq Gold database
Read More
Telomerase gene therapy may offer potential liver cirrhosis therapy
Read More
Myriad Genetics advances drug discovery programs during second quarter
Read More
Anti-tat gene therapy blocks HIV replication, may offer new treatment alternative
Read More
Altus receives funding for GI lipase enzyme therapy
Read More
YM-872 exerts neuroprotective effects in rat transient MCA occlusion model
Read More
Human Genome Sciences moves three drugs into clinical development in 1999
Read More
SkyePharma achieves positive phase II results for DepoMorphine; DepoCyt approved in Canada
Read More
GenVec licenses gene for treating blindness
Read More
New study contradicts earlier indications of efficacy for ERT in treating Alzheimer's disease
Read More
Elan/Endorex joint venture to develop iron-chelating products with Schein
Read More
Modified oligonucleotides with staggered PS/PO linkages designed at Isis
Read More
CAN-296 may inhibit fungal ATPase-mediated proton pumping
Read More
Synaptic discovers potent and selective human alpha1D-adrenoceptor antagonists
Read More
Study disproves earlier reports of serious treatment-related side effect of deferiprone
Read More
NPY Y1-selective compounds for diagnostic, therapeutic use available for licensing
Read More
Compounds activating PPAR isoforms described by Merck for lipid disorders, diabetes
Read More
Salk team identifies potential target for the elusive male contraceptive
Read More
Orally active antiplatelet agents in development at Lafon
Read More
Merck presents new nonpeptide GnRH antagonists
Read More
Immune Response's mbGM-CSF vaccine offers protection against melanoma
Read More
Pregabalin now claimed for renal colic-associated pain
Read More
Ono claims selective EP4 receptor ligands and their use
Read More
New treatment for COPD from Ono to enter clinical trials soon
Read More
AMPA antagonists improve neurological outcome in EAE
Read More
Nastech's NDA for intranasal scopolamine not accepted for filing
Read More
Remicade recommended for approval in E.U. for treatment of rheumatoid arthritis
Read More
FDA issues approvable letter for Pharmacia & Upjohn's Vestra
Read More